Latest Stock Market News

Sanjiv Bhasin says: “There is no such thing as sitting on cash. It is better to be in largecap banks. I still like three PSUs -- IRCTC, CONCOR, and IEX and we are invested in those as a disclosure. They have just started to perform. We are up about 20% on our portfolio on these.”

Taking cues from the international market, MCX February gold futures were trading lacklustre in the opening trade.

Global broking firm Jefferies has reduced its weight on L&T in its model portfolio to neutral and has also told clients that the impact of Budget on some stocks exposed to railway and defence capex program may be subdued.

On Tuesday, the Nifty Pharma index emerged as the leading sectoral performer, showcasing a remarkable surge of over 2%, significantly outpacing the broader indices.

A total of 11,228 shares changed hands on the counter till 11:26AM (IST)

The Relative Strength Index of the stock stood at 55.34 on Wednesday.

Short-term traders can look to buy the stock on dips for a possible target of Rs 372 in the next 3-4 weeks, suggest experts.

The stock quoted a 52-week high price of Rs 2776.3 and a 52-week low of Rs 2250.85.

The stock quoted a 52-week high of Rs 186.2 and a 52-week low of Rs 87.0.